Traceability, testing, and capacity should be key considerations when vetting an ingredient supplier’s non-GMO supply chain capabilities.
I spoke to CRN’s president and CEO, Steve Mister, about the registry’s progress over the past year.
At Capsugel’s Quality Summit, Experts Focus on the Way Forward for Dietary Supplement Quality Control
Quality assurance, compliance, risk management, and best practices were on the minds of 80 quality professionals who convened at the Capsugel Quality Summit in late August.
The Triple-T program takes a three-pronged approach to supply-chain traceability: trace, test, and trust.
CRN Asks International Trade Commission to Reject Amarin’s Omega-3 Complaint, Citing Legal Deficiencies, Harm to Public Interest
In two filings submitted to the International Trade Commission, CRN argued that Amarin was “financially motivated” to expand its near monopoly over a subset of omega-3 products; if successful, CRN says, Amarin’s complaint would make it much more difficult and costly for consumers to access those products.
DolCas Biotech Receives FDA “No Objection” Letter following GRAS Review for BCM-95 Curcumin Ingredient
The company also secured self-affirmed GRAS status for its ingredient back in 2016.
China’s FDA also granted TSI Group expanded Novel Foods usage beyond existing approvals for sports nutrition and medical foods to encompass use in beverages, candies, and baked goods.
Amarin’s Vascepa Omega-3 Drug Aims to Eliminate Dietary Supplement Competition with International Trade Commission Complaint, CRN Says
Amarin’s ITC complaint alleges that synthetically produced omega-3 products that are predominantly composed of EPA in either ethyl ester or re-esterified form are not considered “dietary ingredients” under Section 201(ff)(1) of the Federal Food Drug and Cosmetic Act, and thus, are not legal dietary supplements but unapproved new drugs.
The NPN enables Fruit d’Or’s Cran Naturelle and Cran d’Or cranberry seed oils to make claims as a source of omega-3 and omega-6 fatty acids, antioxidants, oleic acid, and “maintenance of good health.”
According to the company, these patents are expected to “fuel the company’s rapid growth in the cosmetic industry” given consumer demand for products like sunscreen lotions and hair growth formulations.